PDL BioPharma, Inc. Deferred Revenue
PDL BioPharma, Inc. had Deferred Revenue of $864.00 thousand as of 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2020-11-13
- 2020-06-30: Deferred Revenue, Current $864.00K.
- 2020-03-31: Deferred Revenue, Current $933.00K.
- 2019-12-31: Deferred Revenue, Current $959.00K.
- 2019-09-30: Deferred Revenue, Current $4.78M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2020-06-30 | $864.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $933.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $959.00K 10-Q · filed 2020-11-13 |
| 2019-09-30 | $4.78M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $4.80M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $5.37M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $8.81M 10-Q · filed 2019-11-06 |
| 2018-09-30 | $5.33M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $4.90M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $6.97M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $9.74M 10-Q · filed 2018-11-07 |
| 2017-09-30 | $3.76M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $3.18M 10-Q · filed 2017-08-03 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-13 |
| 2016-09-30 | $11.61M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.12M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $541.00K 10-Q · filed 2016-05-04 |
| 2015-12-31 | $87.00K 10-Q · filed 2016-11-03 |
| 2014-09-30 | $1.05M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $553.00K 10-Q · filed 2014-08-18 |
| 2013-12-31 | $0.00 10-Q · filed 2014-11-10 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-01 |
| 2011-12-31 | $1.71M 10-K · filed 2013-03-01 |
| 2011-06-30 | $1.71M 10-Q · filed 2011-07-29 |
| 2011-03-31 | $1.71M 10-Q · filed 2011-04-28 |
| 2010-12-31 | $1.71M 10-K · filed 2012-02-23 |
| 2010-09-30 | $3.21M 10-Q · filed 2010-11-09 |
| 2010-06-30 | $3.21M 10-Q · filed 2010-07-29 |
| 2009-12-31 | $1.60M 10-K · filed 2011-03-01 |